Overview

• The administration has discontinued NIH support for key vaccine studies at Duke Human Vaccine Institute and Scripps Research Institute and paused Moderna’s NIH-backed trial.
• HHS has ordered NIH to halt most new HIV vaccine grants next fiscal year and applied a budget rule that counts entire multi-year awards in a single year.
• In January, PEPFAR disbursements were suspended and domestic CDC HIV prevention funding was slashed, forcing Texas to pause programs and North Carolina to lay off staff.
• Scientists warn ending these research efforts could set vaccine development back by up to a decade and undermine advances in broadly neutralizing antibody studies.
• HHS argues the move will streamline federal resources across more than two dozen overlapping HIV/AIDS initiatives and plans to transfer some work to a proposed Administration for a Healthy America.